Skip to main content

Table 4 Kidney and liver function indicators in the two groups

From: Use of levosimendan combined with Shenfu injection to treat acute heart failure patients with hypotension: a prospective randomized controlled single-blind study

 

Levosimendan

Levosimendan + SFI

P value

Changes in post

24 h-baseline

Changes in post

24 h-baseline

Scr (μmoI/L)

3.45 (− 2.95, 21.25)

5.30 (− 8.00, 23.50)

0.752

BUN (mmol/L)

0.60 (− 1.73, 2.40)

 − 0.04 (− 3.41, 3.45)

0.251

ALT (U/L)

 − 2.50 (− 7.50, 4.50)

 − 2.00 (− 10.00, 7.00)

0.788

AST (U/L)

0.00 (− 10.50, 10.00)

0.00 (− 19.00, 5.00)

0.363

  1. All data are shown as median (IQR)
  2. ALT alanine transaminase, AST aspartate aminotransferase, BUN blood urea nitrogen, Scr serum creatinine, SFI Shenfu injection